OQRO

Ib Acquisition

IBAC · NASDAQ · Health Care · Services-Commercial Physical & Biological Research

Services-Commercial Physical & Biological Research company based in Boca Raton, FL.

Example public filing

SEC Form 4

10% owner sold ~$606K

AQR Capital Management Holdings, 10% owner at Ib Acquisition, sold ~$606K of Ib Acquisition shares.

~$606K
Approx. value · 56K sh @ $10.80
58K
Holds after · shares reported
Traded
Mar 23, 2026
Filed
Mar 26, 2026

Data as of Oct 11, 2026. A real record from the official source, chosen as the most recent insider trade or, failing that, the most recent filing of another kind; not a recommendation.

On file for IBAC, last 12 months

22
Insider filings
0
Congress trades
2
Fund positions
0
Federal contracts

Records OQRO holds, counted by their date; a 13F position is counted once per quarter it is reported.

Insider buying and selling since 2025

Insiders of Ib Acquisition reported 0 open-market purchases and 22 sales since 2025; no open-market purchase.

YearBoughtSold
2026—
11×
2025—
11×

Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.

See the full picture with OQRO Pro.

24 records for Ib Acquisition in the last 12 months, each linked to its filing. Full histories, the screener, alerts for the companies you follow and Ask OQRO.

Latest disclosures

SourceWhoAction
Unlock full access — $9.99/month

Secure payment by Stripe. Renews every month until you cancel; cancel anytime from your account. No free trial.

Continue exploring the free preview

Public previews are free. Full research requires Pro. No free trial.

What this page holds

  • Insider trades and planned sales
  • Politician trades (House and Senate)
  • Fund holdings from 13F filings
  • Federal contracts, lobbying and short selling
  • Full history and context, with a link to every filing

What OQRO is

OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.

Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.

Questions about Ib Acquisition insider trading

Have Ib Acquisition insiders bought shares recently?

No open-market purchase by an insider of Ib Acquisition is on record in SEC filings since 2006.

How often do Ib Acquisition insiders buy and sell shares?

Since 2025, Ib Acquisition insiders reported 0 open-market purchases and 22 sales on Forms 4 and 5.

Do members of Congress trade IBAC?

No trade in Ib Acquisition (IBAC) was disclosed by a member of Congress in the last 12 months.

When does Ib Acquisition report its next results?

Ib Acquisition's next results are expected on Dec 28, 2026. The date can move until the company confirms it. Insiders often trade in the weeks right after results.

Where does this data come from?

From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.

Insiders who traded Ib Acquisition

What this filing is, free to read